Market research

Blood Banking

Explore licenses

360iResearch introduction

Blood Banking: Executive Overview

Blood banking encompasses the collection, testing, processing, storage, distribution, and transfusion of blood and blood components. Its performance depends on safe donor participation, reliable laboratory systems, cold-chain integrity, regulatory compliance, clinical demand, and coordinated emergency preparedness. The sector is also being reshaped by demographic change, surgical activity, trauma care, chronic disease management, and the need for resilient supply systems.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Blood Component Type

    • Cryoprecipitate
    • Plasma
    • Platelets
    • Red Blood Cells
    More in this chapter
  2. Chapter 8 Testing Type

    • Blood Grouping Testing
    • Infectious Disease Testing
    View chapter
  3. Chapter 9 Donor Type

    • Family Replacement Donor
    • Paid Donor
    • Voluntary Donor
    View chapter

How Safety, Resilience, and Automation Are Reshaping Blood Banking

Blood banking is moving toward more standardized, traceable, and digitally connected workflows. Advanced testing, electronic identification, barcode-based inventory control, pathogen-reduction approaches, and improved component separation are strengthening quality management and reducing avoidable errors. At the same time, disruptions caused by extreme weather, infectious-disease events, transport constraints, and donor volatility have increased attention on regional coordination, diversified collection channels, contingency inventories, and workforce readiness.

Artificial Intelligence’s Growing Role in Blood Operations

Artificial intelligence can support donor recruitment, appointment optimization, demand sensing, inventory rotation, image and laboratory interpretation, and detection of unusual operational patterns. Its value depends on representative training data, validated performance, human oversight, cybersecurity, and compliance with medical-device and privacy requirements. Leaders should treat AI as decision support rather than a substitute for transfusion specialists, laboratory governance, clinical judgment, or established safety controls.

Regional Insights Across the Blood Banking Landscape

North America is characterized by mature regulatory frameworks, sophisticated hospital networks, and strong emphasis on automation, traceability, and emergency preparedness. Europe combines advanced transfusion services with cross-border regulatory coordination, while the European landscape continues to address donor sustainability and harmonized safety practices. Asia-Pacific includes highly diverse systems, ranging from advanced national services to capacity-building environments, creating opportunities for interoperable digital infrastructure and workforce development. Latin America is focused on strengthening voluntary donation, testing consistency, logistics, and equitable access. The Middle East is investing in centralized coordination, specialized services, and resilient supply planning. Africa’s priorities include expanding reliable collection, laboratory capacity, cold-chain coverage, and access to safe blood, with regional partnerships supporting implementation.

Group Insights: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members face differing levels of infrastructure maturity, making shared training, interoperable standards, and cross-border emergency coordination particularly valuable. BRICS economies represent diverse operating environments where strengthening domestic collection, laboratory quality, and supply resilience is a common strategic theme. The European Union emphasizes regulatory alignment, traceability, and coordinated public-health standards. G7 members generally prioritize advanced testing, digital integration, donor stewardship, and preparedness for system shocks. GCC countries are emphasizing centralized services, specialized transfusion capabilities, and coordination across rapidly developing healthcare systems. NATO members have a strong interest in medical logistics, trauma readiness, interoperability, and continuity of blood support during crises.

Country Perspectives on Blood Banking Priorities

Australia emphasizes national coordination, donor stewardship, and geographically resilient logistics. Brazil continues to focus on broadening voluntary donation and strengthening coverage across a large territory. Canada prioritizes centralized governance, quality assurance, and continuity across dispersed communities. China is advancing scale, digital coordination, and standardized safety practices. France, Germany, Italy, and Spain combine established transfusion systems with ongoing efforts to improve donor retention, traceability, and operational efficiency. India’s priorities include expanding safe voluntary donation, laboratory capacity, and access across urban and rural settings. Japan emphasizes preparedness, aging-population needs, and highly controlled quality systems. Mexico is focused on improving collection networks, testing, and equitable availability. Russia places importance on national coordination and supply continuity. South Korea combines advanced clinical infrastructure with digital and quality-management capabilities. The United Kingdom emphasizes donor engagement, component stewardship, and system resilience. The United States focuses on supply continuity, automation, regulatory compliance, and response readiness.

Strategic Actions for Blood Banking Leaders

Industry leaders should strengthen donor retention through convenient, trusted, and inclusive engagement programs while maintaining rigorous eligibility and safety controls. They should invest in end-to-end traceability, interoperable information systems, validated automation, and real-time inventory visibility. Supply strategies should include scenario planning for disasters, infectious threats, transportation interruptions, and sudden clinical demand. Organizations should also develop AI governance frameworks covering validation, bias monitoring, explainability, cybersecurity, privacy, and human accountability. Finally, sustained partnerships among blood services, hospitals, regulators, emergency agencies, and community organizations can improve coordination and equitable access.

Research Methodology for the Blood Banking Executive Summary

This summary uses a structured qualitative review of blood-banking system drivers, including donor participation, collection and testing practices, component management, transfusion safety, logistics, regulation, digital transformation, artificial intelligence, healthcare demand, and emergency preparedness. Insights are organized across the required regions, economic and political groups, and countries to identify common priorities and meaningful differences in operating context. The assessment intentionally excludes market estimates, market shares, forecasts, and company-specific analysis, and interprets technology opportunities alongside safety, governance, and implementation requirements.

Conclusion: Building Safer and More Resilient Blood Systems

Blood banking is becoming more integrated, data-driven, and resilience-oriented while retaining safety and human oversight as non-negotiable foundations. Progress will depend on dependable donors, capable laboratories, secure digital infrastructure, skilled personnel, and coordinated public-health planning. Organizations that connect operational modernization with equitable access, transparent governance, and crisis preparedness will be better positioned to support patients and communities across diverse healthcare environments.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Blood Banking Market, by Blood Component Type
    1. 7.1Introduction
    2. 7.2Cryoprecipitate
    3. 7.3Plasma
    4. 7.4Platelets
    5. 7.5Red Blood Cells
    6. 7.6Whole Blood
  8. 8.Blood Banking Market, by Testing Type
    1. 8.1Introduction
    2. 8.2Blood Grouping Testing
    3. 8.3Infectious Disease Testing
  9. 9.Blood Banking Market, by Donor Type
    1. 9.1Introduction
    2. 9.2Family Replacement Donor
    3. 9.3Paid Donor
    4. 9.4Voluntary Donor
  10. 10.Blood Banking Market, by Collection Method
    1. 10.1Introduction
    2. 10.2Whole Blood Collection
    3. 10.3Apheresis Collection
      1. 10.3.1Plateletpheresis
      2. 10.3.2Plasmapheresis
      3. 10.3.3Leukapheresis
  11. 11.Blood Banking Market, by Application
    1. 11.1Introduction
    2. 11.2Diagnostics
    3. 11.3Research
    4. 11.4Transfusion
  12. 12.Blood Banking Market, by End User
    1. 12.1Introduction
    2. 12.2Ambulatory Surgical Centers
    3. 12.3Blood Banks
    4. 12.4Hospitals And Clinics
  13. 13.Blood Banking Market, by Region
    1. 13.1Introduction
    2. 13.2Asia-Pacific
    3. 13.3Europe
    4. 13.4North America
    5. 13.5Latin America
    6. 13.6Africa
    7. 13.7Middle East
  14. 14.Blood Banking Market, by Group
    1. 14.1Introduction
    2. 14.2NATO
    3. 14.3G7
    4. 14.4European Union
    5. 14.5BRICS
    6. 14.6ASEAN
    7. 14.7GCC
  15. 15.Blood Banking Market, by Country
    1. 15.1Introduction
    2. 15.2United States
    3. 15.3China
    4. 15.4Germany
    5. 15.5Japan
    6. 15.6India
    7. 15.7United Kingdom
    8. 15.8France
    9. 15.9Canada
    10. 15.10Italy
    11. 15.11Australia
    12. 15.12South Korea
    13. 15.13Brazil
    14. 15.14Mexico
    15. 15.15Russia
    16. 15.16Spain
  16. 16.Competitive Landscape
    1. 16.1Market Share Analysis, 2025
    2. 16.2Market Concentration Analysis, 2025
      1. 16.2.1Concentration Ratio (CR)
      2. 16.2.2Herfindahl Hirschman Index (HHI)
    3. 16.3Recent Developments & Impact Analysis, 2025
    4. 16.4Product Portfolio Analysis, 2025
    5. 16.5Benchmarking Analysis, 2025
  17. 17.Company Profiles
    1. 17.1Abbott Laboratories
    2. 17.2Arctiko A/S
    3. 17.3BAG Diagnostics GmbH
    4. 17.4Baxter International Inc.
    5. 17.5Beckman Coulter, Inc.
    6. 17.6Becton Dickinson and Company
    7. 17.7Bio-Rad Laboratories, Inc.
    8. 17.8Cardinal Health, Inc.
    9. 17.9Cerus Corporation
    10. 17.10F. Hoffmann-La Roche Ltd.
    11. 17.11Fresenius Kabi AG
    12. 17.12Grifols S.A.
    13. 17.13Haemonetics Corporation
    14. 17.14Helmer Scientific, Inc.
    15. 17.15ICU Medical, Inc.
    16. 17.16Immucor, Inc.
    17. 17.17JMS Transfusion Technology CO., LTD.
    18. 17.18Labcold Ltd.
    19. 17.19Macopharma SA
    20. 17.20Nipro Corporation
    21. 17.21QuidelOrtho Corporation
    22. 17.22Sarstedt AG & Co. KG
    23. 17.23Siemens Healthineers AG
    24. 17.24Span Healthcare Private Limited
    25. 17.25Terumo BCT, Inc.
    26. 17.26Thermo Fisher Scientific Inc.
    27. 17.27Tulip Diagnostics (P) Ltd.
    28. 17.28WellSky Corporation
  18. 18.Key Experts

Loading the sample request form…